Smaller Portions, Protein Everything: How GLP-1s Are Changing Restaurant Menus
They say that the customer is always right. So when two patrons at different tables approached Barry Gutin,…
GLP-1 drugs reshape alcohol consumption and hospitality habits
Millions of Britons using GLP-1 weight loss medications are beginning to alter how they drink, dine and choose…
As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices | Industry News
Â
“It is basically in the injectable space where we have reduced the price because we have…
Boston to curb insurance coverage of GLP-1 drugs for city workers
The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
Novo Nordisk CEO on the company’s developments in weight-loss drugs
Novo Nordisk CEO on the company’s developments in weight-loss drugs ZB Choose a region Shows Slide previous Slide…
Stopping GLP-1 drugs like Ozempic can raise risk of heart attack & death, warns new study | The study published in BMJ Medicine | Inshorts – Inshorts
Stopping GLP-1 drugs like Ozempic can raise risk of heart attack & death, warns new study | The…
How weight loss drugs are changing global consumer behaviour
Click on image for a larger view GLOBAL burger giant McDonald’s is selling a lot more more kid-sized…
India’s coming Ozempic moment could reshape both waistlines and perceptions
On a recent episode of CBS Sports Golazo, Clint Dempsey couldn’t resist a dig. Sitting alongside Thierry Henry,…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
Gabriel Iglesias Says It’s ‘Scary’ How He ‘Immediately Gained Back 20 Pounds’ After Quitting Ozempic
Gabriel IglesiasCredit: Gary Miller/Getty NEED TO KNOW Gabriel Iglesias shared his experience with Ozempic, saying it curbed his…
Is the ‘Ozempic era’ an opportunity for no-and-low?
With growing research to suggest GLP-1 drugs reduce the desire to drink alcohol, Eloise Feilden asks whether the…